In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.
about
In captive rhesus macaques, cervicovaginal inflammation is common but not associated with the stable polymicrobial microbiomeSemen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaquesEffect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeysProtection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccinesImmunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIVSimian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3)Effect of 3-hydroxyphthaloyl-beta-lactoglobulin on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees.Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11.Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infectionEfficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.Does viral tropism play a role in heterosexual transmission of HIV? Findings in the SIV-rhesus macaque modelT cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV.Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses.Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.Differential pathogenicity of SHIV infection in pig-tailed and rhesus macaquesInduction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.Early bone marrow hematopoietic defect in simian/human immunodeficiency virus C2/1-infected macaques and relevance to advance of disease.Inhibition of endogenous reverse transcription of human and nonhuman primate lentiviruses: potential for development of lentivirucides.Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus.Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes.In vivo characterization of macrophage-tropic simian immunodeficiency virus molecular clones in rhesus macaques.
P2860
Q27323257-EAE4F109-D811-47FB-86CD-9F0E1315C838Q27331721-8BEBE1C0-4364-4DA0-B2A2-EB6F8DF05F12Q33595164-99306A29-AF1B-452A-BEC7-429FA91FAD37Q33644522-60081CC2-BBD0-467D-B590-97CFB577411AQ33653655-105246F8-E463-47F8-A4CB-0F07D42998D1Q33786143-A16BFEFA-27A1-42F6-89F1-102DEE6DDE4CQ33806915-24E609AD-49EC-4CD1-B789-FAF4BEE203BEQ33808728-1D58F854-3AD0-4F09-AEC8-4DB73BE3F0D0Q33808774-A8365CC7-5CBA-444D-92BF-DFDDDD174952Q33812016-6B933A8E-0DCA-472C-918D-ED109925F477Q33851266-D31576E5-1B7B-48B3-BAE1-6DCFAF08E1EBQ33855093-E3FDCAFA-EE5E-4D6A-92D6-024F3597C922Q33976772-87907D95-7BA6-4E1B-965F-1DDEEA947A77Q34124090-74C506F7-4737-4DD8-BE50-E95E6642F2A7Q34357324-15AB0DC9-662E-414C-82F4-01B53FBFA8C8Q34464860-375882AC-461B-455A-A195-1E84308D8B92Q34767799-6C6BDE51-A3C8-4FDF-B4E0-58380FA8CDA5Q35104695-94A24C27-A15A-4ED6-AFE2-E2489E15BA2BQ35928138-EB702A49-1C34-440C-8961-5E0FE87C7CD8Q36105919-7652D68D-C9B2-423B-B5E2-DF40BB849006Q36105935-DB4CB2CD-C0B6-4870-8CD0-ED567AC00FF6Q36105939-D39EDA40-89A9-4060-862C-F158621C7B48Q36154787-A3D8D4A8-A1D8-4BAC-B2DE-81C2E95D1662Q36754296-7B00D50B-22BC-4610-8E32-0D522D7EA281Q37309980-00092884-03F6-4F60-9A90-887881AE2540Q37374425-43F62423-B6B8-44D6-A2E6-4EAA5FC0EC3BQ37568263-6E1D1EF8-5A40-472E-B3F3-A79F97C221B0Q38911884-803D1F7F-FF27-49D6-8152-4705CCF87892Q39549352-AD1FBC2D-9D83-4E74-96AB-9E25D4486080Q39615794-CA665907-0727-4DB5-AD8C-8315D6144E76Q42094434-1A3999FA-86BD-46D4-8EED-4BB3A732AD0CQ52623429-2784E47F-C762-4B8E-BBE8-BB8F6A289457
P2860
In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
In vivo replication capacity r ...... ency virus in rhesus macaques.
@ast
In vivo replication capacity r ...... ency virus in rhesus macaques.
@en
type
label
In vivo replication capacity r ...... ency virus in rhesus macaques.
@ast
In vivo replication capacity r ...... ency virus in rhesus macaques.
@en
prefLabel
In vivo replication capacity r ...... ency virus in rhesus macaques.
@ast
In vivo replication capacity r ...... ency virus in rhesus macaques.
@en
P2093
P2860
P1433
P1476
In vivo replication capacity r ...... iency virus in rhesus macaques
@en
P2093
P2860
P304
P577
1998-04-01T00:00:00Z